Funding for this research was provided by:
National Natural Science Foundation of China (81572282)
Natural Science Foundation of Guangdong Province (2015A030313539)
National Key R&D Program of China (2016YFC1303800)
Special Fund for Research in the Public Interest from National Health and Family Planning Commission of PRC (201402031)
Research Fund from Guangzhou Science and Technology Bureau (2014Y2-00545)
Text and Data Mining valid from 2019-04-23
Received: 21 April 2018
Accepted: 31 March 2019
First Online: 23 April 2019
Ethics approval and consent to participate
: The study protocol was approved by the Research Ethics Committee of Guangdong Provincial People’s Hospital. All patients provided written informed consent for participation, with separate consent obtained for tumor specimens for biomarker analyses.
: Not applicable.
: The authors declare that they have no competing interest.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.